PTGS2 and neoplasm: Pre-clinical studies have found that COX-2 overexpression can lead to a higher production of prostaglandin E2 (PGE2), an important mediator of inflammation and contributor to immunosuppression, resulting in cell proliferation, apoptosis inhibition, and tumor angiogenesis (16–18).